Albemarle said it completed the sale of its 51% stake in Ketjen Corporation to ChemCat AcquisitionCo, LLC, an entity affiliated with KPS Capital Partners LP, on March 2, 2026. The company said it retains a 49% stake in Ketjen.

1. 01

   Albemarle said it completed the sale of its 51% stake in Ketjen Corporation to ChemCat AcquisitionCo, LLC, an entity affiliated with KPS Capital Partners LP, on March 2, 2026. The company said it retains a 49% stake in Ketjen.

2. 02

   The company said it expects to receive approximately $547 million in cash from the sale, including $22 million in cash held by Ketjen at the time of the sale.

3. 03

   The company said the combined pre-tax proceeds from the sale of its 50% interest in the Eurecat joint venture to Axens SA, completed in January 2026, and the Ketjen sale total about $670 million. The company said it plans to use the proceeds for debt reduction and other general corporate purposes.

4. 04

   Albemarle said on March 2, 2026 it issued a press release announcing the redemption of its 4.650% Senior Notes due 2027 and tender offers to purchase for cash up to an aggregate purchase price of $500 million across 4 series of senior notes.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.